The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Role of C-Reactive Protein at Sites of Inflammation and Infection
Open accessAbstract
C-reactive protein (CRP) is an acute inflammatory protein that increases up to 1,000-fold at sites of infection or inflammation. CRP is produced as a homopentameric protein, termed native CRP (nCRP), which can irreversibly dissociate at sites of inflammation and infection into five separate monomers, termed monomeric CRP (mCRP). CRP is synthesized primarily in liver hepatocytes but also by smooth muscle cells, macrophages, endothelial cells, lymphocytes, and adipocytes. Evidence suggests that estrogen in the form of hormone replacement therapy influences CRP levels in the elderly. Having been traditionally utilized as a marker of infection and cardiovascular events, there is now growing evidence that CRP plays important roles in inflammatory processes and host responses to infection including the complement pathway, apoptosis, phagocytosis, nitric oxide (NO) release, and the production of cytokines, particularly interleukin-6 and tumor necrosis factor-α. Unlike more recent publications, the findings of early work on CRP can seem somewhat unclear and at times conflicting since it was often not specified which particular CRP isoform was measured or utilized in experiments and whether responses attributed to nCRP were in fact possibly due to dissociation into mCRP or lipopolysaccharide contamination. In addition, since antibodies for mCRP are not commercially available, few laboratories are able to conduct studies investigating the mCRP isoform. Despite these issues and the fact that most CRP research to date has focused on vascular disorders, there is mounting evidence that CRP isoforms have distinct biological properties, with nCRP often exhibiting more anti-inflammatory activities compared to mCRP. The nCRP isoform activates the classical complement pathway, induces phagocytosis, and promotes apoptosis. On the other hand, mCRP promotes the chemotaxis and recruitment of circulating leukocytes to areas of inflammation and can delay apoptosis. The nCRP and mCRP isoforms work in opposing directions to inhibit and induce NO production, respectively. In terms of pro-inflammatory cytokine production, mCRP increases interleukin-8 and monocyte chemoattractant protein-1 production, whereas nCRP has no detectable effect on their levels. Further studies are needed to expand on these emerging findings and to fully characterize the differential roles that each CRP isoform plays at sites of local inflammation and infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“As an acute-phase protein, the plasma concentration of CRP deviates by at least 25% during inflammatory disorders (7).”
BackgroundRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Cytokines, Inflammation, and Pain
Zhang, J.-M., & An, J. (2007) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e318034194e · Cited by 2,945
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · cited 1×
“IL-8 acts as a potent chemoattractant of neutrophils (101) and is overexpressed in chronic inflammatory diseases and during septic shock (102).”
BackgroundDirect Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Pathophysiology of acute wound healing
Li, J., Chen, J., & Kirsner, R. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.09.007 · Cited by 1,486
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C. M., & Mondelli, V (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.67 · Cited by 1,084
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
Human C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
TNF-α signalling and inflammation: interactions between old acquaintances
Zelová, H., & Hošek, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0633-0 · Cited by 853
Venugopal, S. K., Devaraj, S., Yuhanna, I., Shaul, P., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 853
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818 · cited 1×
“The highest concentrations of CRP are found in serum, with some bacterial infections increasing levels up to 1,000-fold (8).”
BackgroundFunction of C-reactive protein
Du Clos, T. W. (2000) · Annals of Medicine · doi:10.3109/07853890009011772 · Cited by 801
Popa, C., Netea, M. G., van Riel, P. L. C. M., van der Meer, J. W. M., & Stalenhoef, A. F. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r600021-jlr200 · Cited by 763
Gershov, D., Kim, S., Brot, N., & Elkon, K. B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1353 · Cited by 695
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672
Clyne, B., & Olshaker, J. S. (1999) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(99)00135-3 · Cited by 668
Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116336 · Cited by 636
C-reactive protein: Ligands, receptors and role in inflammation
Marnell, L., Mold, C., & Du Clos, T. W. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.004 · Cited by 627
Torzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., & Torzewski, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2094 · Cited by 581
Calabró, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Torzewski, J., Torzewski, M., Bowyer, D. E., Fröhlich, M., Koenig, W., Waltenberger, J., Fitzsimmons, C., & Hombach, V. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1386 · Cited by 561
MCP-1: Chemoattractant with a role beyond immunity: A review
Yadav, A., Saini, V., & Arora, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.006 · Cited by 488
The role of interleukin-8 in inflammation and mechanisms of regulation.
Bickel, M. (1993) · PubMed · Cited by 468
Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 443
Ashcroft, G. S., Greenwell-Wild, T., Horan, M. A., Wahl, S. M., & Ferguson, M. W. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65217-0 · Cited by 420
C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive Immunity
Du Clos, T. W., & Mold, C. (2004) · Immunologic Research · doi:10.1385/ir:30:3:261 · Cited by 407
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
Coming of Age of C-Reactive Protein: Using Inflammation Markers in Cardiology
Yeh, E. T. H., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000053731.05365.5a · Cited by 403
Transcriptional Control of Macrophage Polarization
Tugal, D., Liao, X., & Jain, M. K. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301453 · Cited by 399
Palomino, D. C. T., & Marti, L. C. (2015) · Einstein (São Paulo) · doi:10.1590/s1679-45082015rb3438 · Cited by 389
C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction
Lagrand, W. K., Niessen, H. W. M., Wolbink, G.-J., Jaspars, L. H., Visser, C. A., Verheugt, F. W. A., Meijer, C. J. L. M., & Hack, C. E. (1997) · Circulation · doi:10.1161/01.cir.95.1.97 · Cited by 388
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
Pankow, J. S., Folsom, A. R., Cushman, M., Borecki, I. B., Hopkins, P. N., Eckfeldt, J. H., & Tracy, R. P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00586-4 · Cited by 375
The Biology and Medical Implications of Interleukin-6
Tanaka, T., & Kishimoto, T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0022 · Cited by 375
C-reactive protein as a marker of infection in critically ill patients
Póvoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., & Sabino, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01044.x · Cited by 346
Li, J. T. (2009) · JAMA · doi:10.1001/jama.2009.719 · Cited by 332
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Wilson, C., Heads, A., Shenkin, A., & Imrie, C. W. (1989) · Journal of British Surgery · doi:10.1002/bjs.1800760224 · Cited by 319
C-reactive protein and the acute phase response
Pepys, M. B. (1982) · Immunology Today · doi:10.1016/0167-5699(82)90052-4 · Cited by 312
STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6
Zhang, D., Sun, M., Samols, D., & Kushner, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9503 · Cited by 309
Calabro, P., Chang, D. W., Willerson, J. T., & Yeh, E. T. H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.017 · Cited by 308
Tumor necrosis factor‐alpha (TNF‐α) is a therapeutic target for impaired cutaneous wound healing
Ashcroft, G. S., Jeong, M., Ashworth, J. J., Hardman, M., Jin, W., Moutsopoulos, N., Wild, T., McCartney‐Francis, N., Sim, D., McGrady, G., et al. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00748.x · Cited by 285
Self-citationC-reactive protein and inflammation: conformational changes affect function
Wu, Y., Potempa, L. A., El Kebir, D., & Filep, J. G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0149 · Cited by 285
Pentraxins: Structure, Function, and Role in Inflammation
Du Clos, T. W. (2013) · ISRN Inflammation · doi:10.1155/2013/379040 · Cited by 248
C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
Mold, C., Nakayama, S., Holzer, T. J., Gewurz, H., & Du Clos, T. W. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.5.1703 · Cited by 244
C-reactive protein and the acute phase response.
Gewurz, H., Mold, C., Siegel, J. N., & Fiedel, B. A. (1982) · PubMed · Cited by 243
Hage, F. G., & Szalai, A. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.012 · Cited by 241
C-Reactive Protein, Inflammation, and Innate Immunity
Mortensen, R. F. (2001) · Immunologic Research · doi:10.1385/ir:24:2:163 · Cited by 238
The Evolving Role of C-Reactive Protein in Atherothrombosis
Devaraj, S., Singh, U., & Jialal, I. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.108886 · Cited by 233
Kobayashi, S., Inoue, N., Ohashi, Y., Terashima, M., Matsui, K., Mori, T., Fujita, H., Awano, K., Kobayashi, K., Azumi, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081637.36475.bc · Cited by 229
Vascular smooth muscle cell activation by C-reactive protein
HATTORI, Y., MATSUMURA, M., & KASAI, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00855-6 · Cited by 217
Thiele, J. R., Habersberger, J., Braig, D., Schmidt, Y., Goerendt, K., Maurer, V., Bannasch, H., Scheichl, A., Woollard, K. J., von Dobschütz, E., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007124 · Cited by 214
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
Braig, D., Nero, T. L., Koch, H.-G., Kaiser, B., Wang, X., Thiele, J. R., Morton, C. J., Zeller, J., Kiefer, J., Potempa, L. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14188 · Cited by 205
Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element
GUYTON, K. Z., XU, Q., & HOLBROOK, N. J. (1996) · Biochemical Journal · doi:10.1042/bj3140547 · Cited by 201
Ji, S., Wu, Y., Zhu, L., Potempa, L. A., Sheng, F., Lu, W., & Zhao, J. (2007) · The FASEB Journal · doi:10.1096/fj.06-6722com · Cited by 198
Han, K. H., Hong, K.-H., Park, J.-H., Ko, J., Kang, D.-H., Choi, K.-J., Hong, M.-K., Park, S.-W., & Park, S.-J. (2004) · Circulation · doi:10.1161/01.cir.0000131160.94926.6e · Cited by 192
C-REACTIVE PROTEIN FOR RAPID MONITORING OF INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
Peltola, H. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91989-4 · Cited by 190
Topology and Structure of the C1q-Binding Site on C-Reactive Protein
Agrawal, A., Shrive, A. K., Greenhough, T. J., & Volanakis, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3998 · Cited by 187
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1700 · Cited by 186
Devaraj, S., Du Clos, T. W., & Jialal, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168573.10844.ae · Cited by 177
Corcoran, M. P., Meydani, M., Lichtenstein, A. H., Schaefer, E. J., Dillard, A. C., & Lamon‐Fava, S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0057 · Cited by 174
Khreiss, T., József, L., Hossain, S., Chan, J. S. D., Potempa, L. A., & Filep, J. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205378200 · Cited by 167
C-reactive protein: How conformational changes influence inflammatory properties
Eisenhardt, S. U., Thiele, J. R., Bannasch, H., Stark, G. B., & Peter, K. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10068 · Cited by 158
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling
Singh, U. S., Devaraj, S., Vasquez-Vivar, J. M., & Jialal, I. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.015 · Cited by 154
Vongpatanasin, W., Tuncel, M., Wang, Z., Arbique, D., Mehrad, B., & Jialal, I. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00156-6 · Cited by 153
Potempa, L. A., Maldonado, B. A., Laurent, P., Zemel, E. S., & Gewurz, H. (1983) · Molecular Immunology · doi:10.1016/0161-5890(83)90140-2 · Cited by 153
Potempa, L. A., Siegel, J. N., Fedel, B. A., Potempa, R. T., & Gewurz, H. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90028-9 · Cited by 151
Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes
Wigmore, S. J., Fearon, K. C. H., Maingay, J. P., Lai, P. B. S., & Ross, J. A. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e720 · Cited by 150
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2005) · Circulation Research · doi:10.1161/01.res.0000183881.11739.cb · Cited by 141
C-Reactive Protein Induces Apoptosis in Human Coronary Vascular Smooth Muscle Cells
Blaschke, F., Bruemmer, D., Yin, F., Takata, Y., Wang, W., Fishbein, M. C., Okura, T., Higaki, J., Graf, K., Fleck, E., et al. (2004) · Circulation · doi:10.1161/01.cir.0000136999.77584.a2 · Cited by 135
DeCensi, A., Omodei, U., Robertson, C., Bonanni, B., Guerrieri‐Gonzaga, A., Ramazzotto, F., Johansson, H. A., Mora, S., Sandri, M. T., Cazzaniga, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000028463.74880.ea · Cited by 129
C-Reactive Protein: Structure Affects Function
Verma, S., Szmitko, P. E., & Yeh, E. T. H. (2004) · Circulation · doi:10.1161/01.cir.0000127085.32999.64 · Cited by 126
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Osman, R., L’Allier, P. L., Elgharib, N. Z., & Tardif, J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.221 · Cited by 126
Testosterone and IL-6 Requirements for Human C-Reactive Protein Gene Expression in Transgenic Mice
Szalai, A. J., van Ginkel, F. W., Dalrymple, S. A., Murray, R., McGhee, J. R., & Volanakis, J. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5294 · Cited by 124
Monomeric C‐reactive protein modulates classic complement activation on necrotic cells
Mihlan, M., Blom, A. M., Kupreishvili, K., Lauer, N., Stelzner, K., Bergström, F., Niessen, H. W. M., & Zipfel, P. F. (2011) · The FASEB Journal · doi:10.1096/fj.11-186460 · Cited by 121
Healy, B., & Freedman, A. (2006) · BMJ · doi:10.1136/bmj.332.7545.838 · Cited by 116
Slevin, M., Matou, S., Zeinolabediny, Y., Corpas, R., Weston, R., Liu, D., Boras, E., Di Napoli, M., Petcu, E., Sarroca, S., et al. (2015) · Scientific Reports · doi:10.1038/srep13281 · Cited by 115
Khreiss, T., József, L., Potempa, L. A., & Filep, J. G. (2004) · Circulation · doi:10.1161/01.cir.0000146846.00816.dd · Cited by 114
Szalai, A. J., VanCott, J. L., McGhee, J. R., Volanakis, J. E., & Benjamin, W. H. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5652-5656.2000 · Cited by 113
C-Reactive protein in spinal fluid of children with meningitis
Corrall, C. J., Pepple, J. M., Moxon, E. R., et al. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80319-8 · Cited by 110
Singh, G., Jakob, S., Kleedehn, M. G., & Lykke‐Andersen, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.030 · Cited by 101
Boras, E. A., SLEVIN, M. A., Alexander, M. Y., Aljohi, A. O., Gilmore, W., Ashworth, J., Krupiński, J., Potempa, L. A., Abdulkareem, I. A., El‐Obeid, A., et al. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.027 · Cited by 101
Self-citationWeinhold, B., Bader, A., Poli, V., & Rüther, U. (1997) · Biochemical Journal · doi:10.1042/bj3250617 · Cited by 100
Production of Modified C-Reactive Protein in U937-Derived Macrophages
Ciubotaru, I., Potempa, L. A., & Wander, R. C. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001010 · Cited by 90
Localization of C‐reactive protein in synovium of patients with rheumatoid arthritis
Gitlin, J. D., Gitlin, J. I., & Gitlin, D. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200808 · Cited by 88
Sattar, N. A., Perera, M., SMALL, M. P., & Lumsden, M.-A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02079-6 · Cited by 84
RYU, J., Lee, C., Shin, J. H., Park, C.-S., Kim, J., PARK, S., & Han, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.027 · Cited by 79
C-reactive protein and the acute-phase response.
Kushner, I. (1990) · PubMed · Cited by 78
Clos, T. W. D., Mold, C., Paterson, P. Y., Alroy, J., & Gewurz, H. (1981) · PubMed Central · Cited by 64
Novel mechanism of C‐reactive protein for enhancing mouse liver innate immunity†
Inatsu, A., Kinoshita, M., Nakashima, H., Shimizu, J., Saitoh, D., Tamai, S., & Seki, S. (2009) · Hepatology · doi:10.1002/hep.22888 · Cited by 58
Kibayashi, E., Urakaze, M., Kobashi, C., Kishida, M., Takata, M., Sato, A., Yamazaki, K., & Kobayashi, M. (2005) · Clinical Science · doi:10.1042/cs20040315 · Cited by 56
Devaraj, S., Venugopal, S. K., & Jialal, I. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.031 · Cited by 53
Schwedler, S. B., Kuhlencordt, P., Ponnuswamy, P., Hatiboglu, G., Quaschning, T., Widder, J. D., Wanner, C., Potempa, L. A., & Galle, J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.013 · Cited by 51
ABC of wound healing:Infections
Healy, B., & Freedman, A. (2006) · BMJ · doi:10.1136/sbmj.0612454 · Cited by 50
The Role of C-reactive Protein in Innate and Acquired Inflammation: New Perspectives
Trial, J., Potempa, L. A., & Entman, M. L. (2016) · Inflammation and Cell Signaling · doi:10.14800/ics.1409 · Cited by 33
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes
Kurtz, E. G., Ridker, P. M., Rose, L. M., Cook, N. R., Everett, B. M., Buring, J. E., & Rexrode, K. M. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181e750dd · Cited by 28
Diagnosing wound infection: the use of C-reactive protein
Kingsley, A., & Jones, V. J. (2008) · Cited by 26
Regulation of cell function by isoforms of C-reactive protein: a comparative analysis.
Boncler, M. A., & Watała, C. W. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2513 · Cited by 25
Casanova, G. K., dos Reis, A. M., & Spritzer, P. M. (2014) · Climacteric · doi:10.3109/13697137.2014.940309 · Cited by 21
Krayem, I., Bazzi, S. I., & Karam, M. (2017) · Biomedical Reports · doi:10.3892/br.2017.949 · Cited by 17
Cited by
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787
Leng, Z., Zhu, R., Hou, W., Feng, Y., Yang, Y., Han, Q., Shan, G., Meng, F., Du, D., Wang, S., et al. (2020) · Aging and disease · doi:10.14336/ad.2020.0228 · Cited by 1,147
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Metadata
- Authors
- Sproston, N. R., & Ashworth, J. J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-13
- Volume
- 9
- Pages
- 754-754
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2798105113
- Cited by
- 3,029
- References
- 112
- FWCI
- 69.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.